###begin article-title 0
###xml 68 72 <span type="species:ncbi:10090">Mice</span>
Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: EFV. Performed the experiments: JMN XH ES JJ YS EFV. Analyzed the data: JMN XH ES JJ YS ED PY KDM EFV. Contributed reagents/materials/analysis tools: YS CD JM KDM EFV. Wrote the paper: JMN JM KDM EFV.
###end p 1
###begin title 2
Background and Aims
###end title 2
###begin p 3
###xml 371 375 <span type="species:ncbi:10090">mice</span>
Excessive uptake of commensal bacterial antigens through a permeable intestinal barrier may influence host responses to specific antigen in a genetically predisposed host. The aim of this study was to investigate whether intestinal barrier dysfunction induced by indomethacin treatment affects the host response to intestinal microbiota in gluten-sensitized HLA-DQ8/HCD4 mice.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 301 309 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vitro</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
HLA-DQ8/HCD4 mice were sensitized with gluten, and gavaged with indomethacin plus gluten. Intestinal permeability was assessed by Ussing chamber; epithelial cell (EC) ultra-structure by electron microscopy; RNA expression of genes coding for junctional proteins by Q-real-time PCR; immune response by in-vitro antigen-specific T-cell proliferation and cytokine analysis by cytometric bead array; intestinal microbiota by fluorescence in situ hybridization and analysis of systemic antibodies against intestinal microbiota by surface staining of live bacteria with serum followed by FACS analysis. Indomethacin led to a more pronounced increase in intestinal permeability in gluten-sensitized mice. These changes were accompanied by severe EC damage, decreased E-cadherin RNA level, elevated IFN-gamma in splenocyte culture supernatant, and production of significant IgM antibody against intestinal microbiota.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 188 192 <span type="species:ncbi:10090">mice</span>
Indomethacin potentiates barrier dysfunction and EC injury induced by gluten, affects systemic IFN-gamma production and the host response to intestinal microbiota antigens in HLA-DQ8/HCD4 mice. The results suggest that environmental factors that alter the intestinal barrier may predispose individuals to an increased susceptibility to gluten through a bystander immune activation to intestinal microbiota.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Cronin1">[1]</xref>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Rostom1">[2]</xref>
###xml 974 977 974 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Troncone1">[3]</xref>
###xml 978 981 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Verd1">[7]</xref>
###xml 1112 1115 1112 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Black1">[8]</xref>
###xml 1291 1294 1291 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Black1">[8]</xref>
###xml 1295 1299 1295 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Verdu1">[11]</xref>
###xml 1480 1484 1480 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Verdu1">[11]</xref>
###xml 1626 1630 1626 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Pinier1">[12]</xref>
###xml 161 166 <span type="species:ncbi:4565">wheat</span>
###xml 1148 1163 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of gluten containing cereals, and in particular gliadin, the storage protein in wheat. It has recently been recognized that both the pathology and the clinical spectrum of CD varies considerably from severe to subtle, and that the clinical expression is not restricted to the presence of mucosal atrophy [1], [2]. The concept of gluten sensitivity (GS) incorporates a variety of pathologic, immunological, and clinical scenarios that may, or may not, form part of the "celiac" spectrum such as gluten-sensitive diarrhea, immunological mucosal response to gluten in family members of celiac disease, persistent positive specific serology for celiac disease in the absence of defined enteropathy, and subtle immunopathological changes in the intestine exposed to gluten. Typically, these disorders occur in individuals who carry the same HLA genotypes associated with celiac disease-DQ2 and DQ8 [3]-[7]. This has led to the development of animal models of gluten-sensitivity that mimic certain aspects of gluten-induced pathogenesis [8]. HLA-DQ8/HCD4 or single HLA-DQ8 transgenic mice that are sensitized with gluten develop an immune response to gliadin that involves both the adaptive and innate immune system [8]-[11]. Although these gluten-sensitive mice do not spontaneously develop intestinal atrophy, they exhibit gluten-dependent changes in gut neuromuscular and epithelial secretory function [11]. This model has proven useful for the preclinical testing of novel experimental therapies designed to block gluten-induced mucosal pathology [12].
###end p 9
###begin p 10
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Green1">[13]</xref>
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Rostom1">[2]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Green1">[13]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Kagnoff1">[14]</xref>
###xml 709 716 709 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Dieterich1">[15]</xref>
###xml 899 903 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Dieterich1">[15]</xref>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
###xml 811 819 <span type="species:ncbi:9606">patients</span>
The presence of HLA-DQ2/DQ8 genes are necessary but not sufficient for the development of CD [13], as up to 25-40% of general populations in United States carry these genes and eat gluten, but do not develop a celiac lesion [2], [13], thus raising the possibility of contributing environmental and genetic risk factors yet to be identified [14]. The net availability of gliadin to the lamina propria seems to be an important factor in the inflammatory response of celiac patients. The immobilization and haptenation of gluten components to the extracellular matrix proteins by tissue transglutaminase aids and allows reservoirs of antigenically potentiated gluten components to reach increased concentrations in vivo, and may even induce a widespread mucosal response against auto-antigens [15]. Indeed, celiac patients have been shown to increase systemic titres of IgA antibodies against collagen [15].
###end p 10
###begin p 11
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Fasano1">[16]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Arrieta1">[18]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Bjarnason1">[19]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Bjarnason2">[20]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-vanElburg1">[21]</xref>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
Under normal conditions, the intestinal epithelium acts as a protective barrier restricting transport of luminal antigens, and only allows small and selective quantities to permeate the mucosa [16]-[18]. In contrast, increased intestinal permeability has been demonstrated in patients with active CD [19], [20] and their healthy relatives, suggesting that in a proportion of cases, intestinal barrier abnormalities may predate overt inflammation [21]. Altered barrier function could be a critical step in facilitating the host responses that contribute to the clinical expression of gluten sensitivity. Thus, the present study was designed to investigate whether alteration of intestinal barrier function using the non-steroidal anti-inflammatory drug (NSAID), indomethacin, enhances gluten-induced epithelial injury and influences subsequent host responses to gut luminal antigens. Our results show that indomethacin enhances gluten-induced changes in the mucosa leading to increased IFN-gamma release by gliadin-stimulated splenocytes and to systemic priming against intestinal microbiota antigens. In genetically predisposed hosts with long standing barrier abnormalities, this mechanism may lower the threshold of inflammatory responses to specific antigens.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Gluten sensitization and indomethacin treatment led to retardation of weight gain
###end title 13
###begin p 14
###xml 307 316 307 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s001">Figure S1</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
Gluten sensitized mice and non-sensitized mice treated with indomethacin exhibited a mild retardation of weight gain after 7 weeks compared to non-sensitized controls. Gluten-sensitized mice treated with indomethacin exhibited a more severe retardation of weight gain after 7 weeks, compared to all groups (Figure S1). These results suggest delayed thriving in mice treated with both gluten and indomethacin.
###end p 14
###begin title 15
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Indomethacin increased tissue conductance and permeation of macromolecules across epithelium in gluten-sensitized mice
###end title 15
###begin p 16
###xml 385 394 385 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g001">Figure 1A</xref>
###xml 697 706 697 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g001">Figure 1B</xref>
###xml 894 903 894 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s002">Figure S2</xref>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
In order to determine the effects of gluten sensitization and indomethacin treatment on intestinal permeability, tissue conductance and HRP flux were measured in segments of small intestine. Gluten-sensitized mice treated with indomethacin exhibited a significant increase in small intestinal tissue conductance compared to non-sensitized controls and indomethacin alone-treated mice (Figure 1A). HRP flux, a measurement of transcellular macromolecular transport, was elevated in all groups compared to non-sensitized controls. Gluten sensitization and indomethacin treatment, however, led to the highest increase in HRP flux with approximately 2.5 fold increase compared non-sensitized controls (Figure 1B). The potentiation of intestinal permeability changes by indomethacin was not observed in C57BL/6 mice sensitized with gluten, stressing the importance of the DQ8 transgene in the model (Figure S2).
###end p 16
###begin title 17
Intestinal barrier measurements.
###end title 17
###begin p 18
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
Ussing-chamber experiments were performed on jejunum from all four groups 24 hours after the last gluten challenge. (A) Gluten-sensitized mice treated with indomethacin showed a significant increase in tissue conductance. (B) HRP flux (transcellular permeability) increased significantly in all treatment groups compared to non-sensitized controls, however the highest values were observed in gluten plus indomethacin treated mice. Data represent the means+/-SEM of 10 mice/group.
###end p 18
###begin title 19
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Indomethacin led to epithelial ultra-structural damage in gluten-sensitized mice
###end title 19
###begin p 20
###xml 185 196 185 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g002">Figure 2A,B</xref>
###xml 282 291 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g002">Figure 2C</xref>
###xml 350 359 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g002">Figure 2D</xref>
###xml 500 509 500 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g002">Figure 2E</xref>
###xml 832 840 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g003">Figure 3</xref>
###xml 921 930 921 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g003">Figure 3C</xref>
###xml 969 978 969 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g003">Figure 3D</xref>
###xml 1102 1113 1102 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g003">Figure 3E&#8211;G</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1096 1100 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
Intestinal morphology was analyzed using electron microscopy. No mitochondrial abnormalities were detected in non-sensitized controls or in gluten-sensitized mice without indomethacin (Figure 2A,B). Mitochondrial abnormalities were observed in mice treated with indomethacin alone (Figure 2C) and in gluten-sensitized mice treated with indomethacin (Figure 2D). We quantified the proportion of mitochondria with disrupted cristae in a defined area with approximately the same number of mitochondria (Figure 2E). Gluten-sensitized mice treated with indomethacin, had a higher proportion of damaged mitochondria than gluten-sensitized mice without indomethacin. Epithelial cell edema and disrupted microvilli were observed in tissues obtained from gluten-sensitized plus indomethacin treated mice but not from the rest of the groups (Figure 3). These marked ultra-structural changes were not observed in gluten-sensitized (Figure 3C) and indomethacin alone-treated mice (Figure 3D). Altered junctional ultra-structure was more pronounced in tissues from gluten-sensitized plus indomethacin-treated mice (Figure 3E-G) compared to non-sensitized (A-B), gluten-sensitized (C) and indomethacin alone-treated mice (D).
###end p 20
###begin title 21
Evaluation of mitochondrial disruption.
###end title 21
###begin p 22
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
Mitochondrial ultra-structure was assessed by electron microscopy. Indomethacin increased the fraction of disrupted mitochondria. Gluten sensitization plus indomethacin treatment further increased the proportion of altered mitochondria. Data represent the means+/-SEM of 6 mice/group. Reperesentative pictures from (A) Control mouse, arrow: normal mitochondria; (B) Gluten-sensitized mouse; (C) Indomethacin-treated mouse, arrowhead: mitochondria with disrupted cristae; (D) Indomethacin-treated plus gluten-sensitized mouse, arrowhead: mitochondria with disrupted cristae.
###end p 22
###begin title 23
Apical epithelial cell structural abnormalities.
###end title 23
###begin p 24
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 541 546 <span type="species:ncbi:10090">mouse</span>
###xml 623 628 <span type="species:ncbi:10090">mouse</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
###xml 817 822 <span type="species:ncbi:10090">mouse</span>
Epithelial ultra-structure was assessed by electron microscopy. A significant proportion of altered TJ was observed in gluten-sensitized plus indomethacin-treated mice. Indomethacin alone also increased the proportion of altered TJ but to a lesser extent than indomethacin plus gluten. Gluten sensitization alone tended to increase the proportion of altered TJ but this did not achieve statistical significance (p = 0.09 vs non-sensitized controls). Data represent the means+/-SEM of 5 mice/group. Representative pictures of (A-B) a control mouse, arrow: tight junction (TJ) with preserved structure; (C) Gluten-sensitized mouse, arrow: TJ with preserved structure; (D) Indomethacin-treated mouse showing one altered TJ (arrowhead) and 2 junctions with normal struture (arrows); (E-G) Gluten plus indometacin treated mouse; (E) arrowhead: microvilli (mv) height reduction, arrow: apical epithelial cell destruction; (F) Altered TJ, arrow: mitochondria (m) with disrupted cristae; (G) Several altered TJs.
###end p 24
###begin title 25
Concomitant treatment with indomethacin and gluten led to reduction of E-cadherin mRNA expression
###end title 25
###begin p 26
###xml 418 426 418 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g004">Figure 4</xref>
###xml 717 726 717 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s003">Figure S3</xref>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
The changes in the ultra-structure of the tight junctions prompted us to investigate whether there were alterations in RNA expression of epithelial adherens and tight junctional proteins. Gluten-sensitized and indomethacin alone-treated mice showed reduced E-cadherin RNA expression by a mean factor of 0.762 and 0.533 respectively, but this did not achieve statistical difference relative to non-sensitized controls (Figure 4). In contrast, expression of E-cadherin RNA was markedly down regulated by 2.75 fold compared to non-sensitized mice, in gluten-sensitized plus indomethacin-treated mice. Gluten sensitization and indomethacin did not affect significantly the relative RNA expression of tight junction ZO-1 (Figure S3).
###end p 26
###begin title 27
RNA level of E-cadherin relative to control (non-sensitized).
###end title 27
###begin p 28
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
Real-time QPCR experiments were performed on jejunum collected from all groups 24 hours after the last gluten challenge. Gluten-sensitized and indomethacin alone-treated mice showed a trend for decreased expression of E-cadherin relative to non-sensitized controls. Gluten-sensitized plus indomethacin-treated mice showed marked down-regulation of E-cadherin RNA level relative to non-sensitized controls. Data represent the means+/-SEM of 6 mice/group.
###end p 28
###begin title 29
###xml 106 114 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Indomethacin treatment affected the release of IFN-gamma by splenocytes from gluten-sensitized mice after in vitro challenge with PT-gliadin
###end title 29
###begin p 30
###xml 444 452 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g005">Figure 5</xref>
###xml 829 837 829 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g005">Figure 5</xref>
###xml 840 848 840 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-vitro</italic>
###xml 958 967 958 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s004">Figure S4</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
In order to assess whether the increase in permeability and the damage to the intestinal structure in gluten-senstized mice after treatment with indomethacin led to an increase in the systemic immune response to gliadin, we analyzed antigen-specific proliferation and cytokine production of splenocytes. Increased T cell proliferation after incubation with PT-gliadin was observed in gluten-sensitized mice, but not in non-sensitized controls (Figure 5). Differences in proliferation did not reflect cell death or an inability to proliferate as polyclonal stimulation with ConA led to equal responses in all groups (data not shown). Surprisingly, indomethacin-treatment of gluten-sensitized mice did not exhibit higher levels of antigen-specific proliferation compared to gluten-sensitized mice that were not given indomethacin (Figure 5). In-vitro incubation of splenocytes from gluten-sensitized mice with indomethacin did not increase cell proliferation (Figure S4).
###end p 30
###begin title 31
Splenocyte proliferation after incubation with PT gliadin.
###end title 31
###begin p 32
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
Proliferation was measured by 3H-thymidine incorporation and expressed as stimulation index. Splenocytes from gluten-sensitized mice treated with or without indomethacin exhibited increased proliferation compared to non-sensitized controls. Data represent the means+/-SEM of 6 mice/group.
###end p 32
###begin p 33
###xml 167 175 163 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g006">Figure 6</xref>
###xml 389 397 385 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
To further assess the systemic immune response IL-12, IFN-gamma and IL-10 levels in the supernatant of the PT-gliadin stimulated splenocytes cultures were determined (Figure 6). Whilst IL-12 was not induced above media alone, IL-10 levels were slightly increased in the culture supernatant of splenocytes from gluten-sensitized and indomethacin-treated gluten-sensitized splenocytes after in vitro stimulation with PT-gliadin, although the increases were not statistically significant.
###end p 33
###begin title 34
Cytokines in supernatant of splenocyte cultures after incubation with PT-gliadin (black) or medium (white).
###end title 34
###begin p 35
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
Expressions of (A) IL-12p70, (B) IFN-gamma, (C) IL-10 were determined by CBA analysis. Culture supernatants from gluten-sensitized plus indomethacin (Indo) treated mice showed increased IFN- gamma (*p<0.01 vs all groups). Cultured splenocytes from gluten-sensitized mice, with or without indomethacin showed a trend for increased IL-10 release after PT-gliadin stimulation (p = 0.09). Data represent the means+/-SEM of 6 mice/group.
###end p 35
###begin p 36
###xml 155 163 151 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-vitro</italic>
###xml 275 284 267 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s005">Figure S5</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
In contrast, indomethacin treatment of gluten-sensitized mice led to a significant increase in IFN-gamma production in response to PT-gliadin stimulation. In-vitro incubation of splenocytes from gluten-sensitized mice with indomethacin did not increase IFN-gamma production (Figure S5).
###end p 36
###begin title 37
Gluten and indomethacin led to changes in intestinal microbiota composition
###end title 37
###begin p 38
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 240 262 240 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. rectale-Clostridium</italic>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 399 421 399 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacteroides-Prevotella</italic>
###xml 665 673 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g007">Figure 7</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 228 235 <span type="species:ncbi:562">E. coli</span>
###xml 240 250 <span type="species:ncbi:39491">E. rectale</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 352 359 <span type="species:ncbi:562">E. coli</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
We next analyzed whether gluten sensitization or indomethacin treatment could lead to changes in the composition of the intestinal microflora. Gluten-sensitized mice showed a significant decrease of gut bacterial proportions of E. coli and E. rectale-Clostridium groups, as compared to control mice. Indomethacin-treated mice also showed reductions in E. coli proportions, but increases in those of Bacteroides-Prevotella group. Gluten-sensitized mice treated with indomethacin showed the most remarkable alterations in the intestinal microbiota, characterized by reductions in the relative abundance of all bacterial groups analysed as compared with control mice (Figure 7).
###end p 38
###begin title 39
Microbiota composition.
###end title 39
###begin p 40
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
Using 9 different oligonucleotide probes and fluorescent in situ hybridization (FISH), microbial profile was investigated in the distal jejunum of sensitized mice with and without indomethacin. The results indicate a significant perturbation in the proportions of microbiota investigated in all 3 treatment-groups when compared to non-sensitized controls, and remarkably in the gluten-sensitized plus indomethacin group. These differences achieve statistical significance in Bifidobacteria (*p = 0.04 vs controls, +p = 0.03 vs gluten) and Clostridium Leptum cluster (both *p = 0.02 vs controls and gluten sensitized, **p = 0.04 vs indomethacin) compared to gluten-sensitized alone. Data represent the means+/-SEM of 6 mice/group.
###end p 40
###begin title 41
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Indomethacin led to systemic priming against intestinal microbiota in gluten-sensitized mice
###end title 41
###begin p 42
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-MatysiakBudnik1">[26]</xref>
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006472-g008">Figure 8</xref>
###xml 635 644 635 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s006">Figure S6</xref>
###xml 1130 1139 1130 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s007">Figure S7</xref>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 1097 1101 <span type="species:ncbi:10090">mice</span>
Previous data suggests that bacterial translocation beyond the mucosal immune system is necessary for systemic priming to intestinal commensals [26]. To determine if the increased conductance and HRP flux induced by gluten-sensitization and indomethacin was accompanied by loss of the host's normal systemic ignorance to the intestinal microbiota, we measured specific IgM antibody responses to culturable aerobic or anaerobic commensals. Non-sensitized mice showed no evidence of IgM specific antibodies against aerobic and anaerobic commensal flora as assessed by flow cytometric analysis of anti-bacterial IgM responses (Figure 8 & Figure S6). Treatment with either gluten or indomethacin alone led to the production of very low titres of IgM antibodies directed against a subset of culturable bacteria. Gluten sensitization plus indomethacin treatment, however, resulted in induction of strong specific IgM responses directed against 40-80% of culturable bacteria. The anti-bacterial IgM induced was specific to the commensal microflora of the host and did not bind to Salmonella, which these mice have never been exposed to (Figure S7). These data indicate that the combination of gluten-sensitization and increased intestinal permeability as induced by indomethacin treatment increased systemic priming to the commensal microflora.
###end p 42
###begin title 43
Systemic antibodies against commensals.
###end title 43
###begin p 44
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
Serum from indomethacin and gluten treated mice showed significant positive serum antibodies against their aerobic and anaerobic intestinal microbiota. (A) Representative FACS histogram from each treatment gated on IgM+ cells; (B) Proportion of IgM+ aerobic bacterial cells for each treatment groups; (C) Proportion of IgM+ anaerobic bacterial cells for each treatment groups. Data represent the means+/-SEM of 6 mice/group.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Drago1">[22]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Clemente1">[25]</xref>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-MatysiakBudnik1">[26]</xref>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
The aim of this study was to investigate whether modulation of the intestinal barrier by an environmental trigger can affect host responses to luminal antigens in a genetically predisposed host. Our results demonstrate that gluten sensitization and long-term gluten challenge in HLA-DQ8/HCD4 mice alters intestinal permeability as assessed by increased transcellular macromolecular transport and a tendency for higher conductance values (paracellular pathway). This is in agreement with previous reports showing that gluten peptides have the ability to rapidly disrupt the apical junctional structure [22]-[25], and can also be transported by an abnormal transcellular route [26]. Administration of indomethacin to gluten-sensitized mice led to more pronounced barrier dysfunction, which was accompanied by a mild pro-inflammatory shift with marked changes in EC ultra-structure, reduced E-cadherin mRNA levels in the proximal small intestine and generation of systemic antibody responses to intestinal microbiota.
###end p 46
###begin p 47
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Porras1">[27]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sigthorsson1">[28]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Porras1">[27]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Berg1">[29]</xref>
###xml 1018 1027 1018 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s002">Figure S2</xref>
###xml 1499 1503 1499 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Guo1">[30]</xref>
###xml 1505 1509 1505 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sander2">[31]</xref>
###xml 1615 1619 1615 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Barshak1">[32]</xref>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
###xml 1359 1363 <span type="species:ncbi:10090">mice</span>
###xml 1547 1555 <span type="species:ncbi:9606">children</span>
###xml 2008 2012 <span type="species:ncbi:10090">mice</span>
Indomethacin has been used at higher doses as a model of inflammatory bowel disease (IBD) [27], [28], and has been shown to compromise epithelial barrier integrity and function, induce motility changes, and promote small intestinal bacterial overgrowth and translocation [27], [29]. In the present manuscript, low-dose indomethacin induced permeability changes without producing macroscopic or microscopic ulcers. However, ultra-structural observations revealed epithelial cell abnormalities characterized by mitochondria with disrupted cristae in mice receiving indomethacin. Mucosal toxicity induced by gluten in HCD4/DQ8 mice was potentiated by indomethacin, as shown by more marked elevation of HRP flux and a significant increase in tissue conductance. After administration of indomethacin, C57BL/6 mice exhibited increased HRP flux, but no change in tissue conductance. Gluten sensitization however, did not induce barrier dysfunction in C57Bl6 mice, emphasizing the relevance of the DQ8 transgene in the model (Figure S2). Electron microscopy examination in gluten-sensitized HCD4/DQ8 mice treated with indomethacin revealed more structural abnormalities in the apical region of the epithelium compared to gluten alone-treated mice. Furthermore, RT-PCR analysis demonstrated reduced E-cadherin RNA levels in gluten-sensitized plus indomethacin treated mice. E-cadherin is required for TJ formation and there is growing evidence for its role as modulator of TJ and intestinal barrier function [30], [31]. E-cadherin expression is reduced in children with CD and gliadin has been shown to alter its expression [32]. Our results support the hypothesis that both gluten and indomethacin play a role in the expression of E-cadherin, and that this effect is potentiated in a genetically susceptible host when both agents are administered together. Marked reduction of E-cadherin may constitute a mechanism for the enhanced barrier dysfunction observed in gluten-sensitized and indomethacin-treated HCD4/DQ8 mice.
###end p 47
###begin p 48
###xml 498 502 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Newberry1">[33]</xref>
###xml 611 615 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Newberry1">[33]</xref>
###xml 635 643 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
The marked changes in barrier function in gluten-sensitized plus indomethacin-treated mice were accompanied by increased IFN-gamma production in splenocyte cultures after incubation with PT-gliadin. These results suggest a shift towards a mild systemic pro-inflammatory state. Previous studies have shown that cyclooxygenase-2 (COX-2)-dependent arachidonic acid metabolites are important in the maintenance of intestinal immune homeostasis, particularly in the immunoregulation of dietary antigens [33]. Consequently, COX-2 inhibitors such as indomethacin may exacerbate the immune response to dietary antigens [33]. Our results using in vitro incubation of splenocytes with PT gliadin and indomethacin, however, do not support a direct effect of indomethacin on splenocyte proliferation and IFN-gamma release. Thus, we hypothesize that the shift in the immune response may be due to an enhanced uptake of luminal contents, including commensal bacteria, through a more structurally damaged and permeable epithelium.
###end p 48
###begin p 49
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Fasano1">[16]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Yu1">[34]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Robert1">[35]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Verdu1">[11]</xref>
###xml 865 869 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Porras2">[36]</xref>
###xml 943 947 943 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Porras2">[36]</xref>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Dalby1">[37]</xref>
###xml 1449 1453 1449 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Macpherson1">[17]</xref>
###xml 1455 1459 1455 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Macpherson2">[38]</xref>
###xml 2022 2026 2022 2026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Furst1">[39]</xref>
###xml 2323 2324 2323 2324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2430 2439 2430 2439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s008">Figure S8</xref>
###xml 2441 2452 2441 2452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s010">Protocol S1</xref>
###xml 2676 2686 2676 2686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 2838 2847 2838 2847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s007">Figure S7</xref>
###xml 3111 3115 3111 3115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Macpherson3">[40]</xref>
###xml 3788 3792 3788 3792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Ford1">[41]</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10116">rats</span>
###xml 563 567 <span type="species:ncbi:10116">rats</span>
###xml 1091 1095 <span type="species:ncbi:10090">mice</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
###xml 1569 1573 <span type="species:ncbi:10090">mice</span>
###xml 1642 1646 <span type="species:ncbi:10090">mice</span>
###xml 2395 2399 <span type="species:ncbi:10090">mice</span>
###xml 2581 2585 <span type="species:ncbi:10090">mice</span>
###xml 2739 2743 <span type="species:ncbi:10090">mice</span>
###xml 2832 2836 <span type="species:ncbi:10090">mice</span>
The intestinal epithelium regulates permeation of luminal antigens and excessive immune activation within the mucosa [16], [34]. The marked barrier defect in gluten-sensitized mice treated with indomethacin may not only allow an increased influx of gliadin peptides across the epithelium but also of other luminal antigens such as intestinal microbiota with potential bystander, pro-inflammatory effects. Germ-free rats have been reported to have a higher threshold for intestinal damage after indomethacin administration compared to specific pathogen-free (SPF) rats [35]. Since inhibition of prostaglandins in the absence of an intestinal microbiota is less severe, the results raise the hypothesis that intestinal bacteria potentiate the development of indomethacin-induced mucosal lesions. Thus, dysmotility induced by gluten sensitization [11] or indomethacin [36], and/or the ability of indomethacin to induce small intestinal dysbiosis [36], [37] may facilitate bacterial translocation. Due to a severely impaired intestinal barrier in both gluten-sensitized and indomethacin-treated mice, increased permeation of luminal bacteria may disturb the natural commensal homeostasis in the gut promoting a pro-inflammatory response. SPF mice have been shown to be systemically ignorant to their intestinal microbiota due to the geographic and functional separation between the mucosal and systemic immune system by the mesenteric lymph nodes (MLN) [17], [38]. Our results show, however, that a low level of systemic priming against intestinal microbiota occurs in SPF mice treated with either gluten or indomethacin alone. Gluten-sensitized mice, in which barrier function is further perturbed by indomethacin treatment, show dramatic systemic priming to their intestinal microbiota. These data therefore imply that gluten-sensitization, in combination with indomethacin treatment, results in decreased mucosal containment of the commensal flora. NSAIDs have been shown to reduce the phagocytic properties of macrophages [39]. Thus, we acknowledge that it is possible that in addition to changes in intestinal barrier function, indomethacin may have a dual effect by inhibiting macrophage function, allowing the persistence of live bacteria, and facilitating a systemic immune response against intestinal microbiota. F4/80+ cell counts in the lamina propria of gluten plus indomethacin-treated mice were significantly increased (Figure S8, Protocol S1), however macrophage function was not assessed. The exact identities of the commensals to which gluten and indomethacin-treated mice are systemically primed in this model are not yet known but the absence of IgM binding to Salmonella, known to be absent from the commensal flora of our mice, strongly suggests the specificity of the IgM antibodies against commensal flora in our mice (Figure S7). The clinical relevance of the loss of systemic ignorance against the intestinal microbiota remains to be established, however, systemic priming to the commensal flora represents a significant shift in the normal relationship between host and commensal bacteria [40]. Consequently, this may indicate a novel mechanism that could contribute to the progression of disease in a gluten-sensitive host. On the other hand, specific IgM against flora may be part of a protective mechanism mounted by the immune system to limit subsequent translocation and widespread inflammation. Additional host factors, such as an underlying immune dysbalance, may play a role in determining whether this mechanism will become maladaptive and contribute to widespread inflammation. A recent epidemiological study has determined that consumption of non-steroidal anti-inflammatory drugs (NSAIDs) is a risk factor for the development of irritable bowel syndrome [41]. No epidemiological studies to date have investigated whether a history of NSAID consumption is also a risk factor for the protean clinical expression in gluten sensitivity.
###end p 49
###begin p 50
###xml 107 126 107 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-TlaskalovaHogenova1">[for review see 42]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Forsberg1">[43]</xref>
###xml 505 529 505 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 540 563 540 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas fluorescens</italic>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Ashorn1">[44]</xref>
###xml 939 961 939 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccaromyces cervisiae</italic>
###xml 1083 1087 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-MallantHent1">[45]</xref>
###xml 1341 1345 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sollid1">[46]</xref>
###xml 1347 1351 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sollid2">[47]</xref>
###xml 1425 1444 1425 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lactobacillus casei</italic>
###xml 1563 1567 1563 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-DArienzo1">[48]</xref>
###xml 1904 1908 1904 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Nadal1">[49]</xref>
###xml 1910 1914 1910 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sanz1">[50]</xref>
###xml 2198 2202 2198 2202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Verdu1">[11]</xref>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
###xml 405 413 <span type="species:ncbi:9606">patients</span>
###xml 505 529 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 540 563 <span type="species:ncbi:294">Pseudomonas fluorescens</span>
###xml 687 694 <span type="species:ncbi:9606">patient</span>
###xml 1385 1389 <span type="species:ncbi:10090">mice</span>
###xml 1425 1444 <span type="species:ncbi:1582">Lactobacillus casei</span>
###xml 1858 1866 <span type="species:ncbi:9606">patients</span>
###xml 2042 2046 <span type="species:ncbi:10090">mice</span>
Although the role of the intestinal microbiota in other chronic diseases of the gut is clearly established [for review see 42] little is known about the role of abnormal immune responses to commensals in gluten and other food intolerances. Recent findings, however, report presence of rod-shaped bacteria in the mucosa of active and non-active celiac patients but not in healthy controls [43]. A study in patients with CD revealed the presence of serological responses to microbial antigens, such as anti-Saccharomyces cerevisiae, anti-I2 (Pseudomonas fluorescens) and anti-ompW, compared to healthy controls. Interestingly, microbial seropositivity was also present in gluten-sensitive patient with no evidence of active CD. However, increasing age was associated with sero-reactivity for anaerobic bacteria, possibly reflecting exposure to different environmental antigens with longer duration of disease [44]. The disappearance of anti-Saccaromyces cervisiae-antibodies (ASCA) after a gluten-free diet suggests that healing of mucosal lesions is related to microbial sero-markers [45]. However, a causal relationship between gut dysfunction, symptoms and microbial sero-responses in CD remains to be determined. It is possible that accumulated bacterial products have a bystander effect and lower the threshold for immune cell activation [46], [47]. To this respect, a study in DQ8 mice has shown that oral challenge with Lactobacillus casei at the time of mucosal sensitization with gliadin and cholera toxin exacerbates the Th1 response induced in the model [48]. Thus, it is possible that dysbiosis or shifts in the composition of the intestinal microbiota at the time of gluten sensitization, and not necessarily the presence of a pathogen, contribute to enhance gluten-induced immune responses. An altered microbiota composition has been reported in patients with CD compared to healthy controls [49], [50]. In this study, we observed significant alterations in the composition of the small intestinal microbiota in gluten-sensitized mice treated with indomethacin. It is unclear, however, if these changes are primary or secondary to the functional gut abnormalities observed in the model [11].
###end p 50
###begin p 51
In conclusion, our findings suggest that an environmental alteration of the intestinal barrier plays a critical role in determining host immune responses to gluten and intestinal microbiota antigens. Bystander luminal antigens such as components of the intestinal microbiota may contribute to enhance inflammatory responses to dietary antigens such as gluten. This mechanism may become important in genetically predisposed hosts with longstanding barrier abnormalities. The results warrant further investigations on the interactions between host genotype, diet, and intestinal microbiota.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Animals
###end title 53
###begin p 54
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Black1">[8]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Cheng1">[51]</xref>
###xml 102 117 <span type="species:ncbi:10090">transgenic mice</span>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 247 262 <span type="species:ncbi:10090">transgenic mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">Mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
All experiments were conducted with approval from the McMaster University Animal Care Committee. Male transgenic mice expressing HLA-DQ8 genes (HLA-DQA1*0301; HLA-DQb1*0302) in the absence of endogenous mouse class II genes or HLA-DQ8/HCD4 double transgenic mice were used [8], [51]. The mice were bred in a conventional specific pathogen free colony (SPF) at McMaster University and maintained for at least 2 generations prior to breeding on a gluten-free diet (Bio-Serv, New Jersey). Mice were used at the age of 8-14 weeks. Male C57BL/6 mice were purchased from Taconic (Hudson, NY, USA) (supplementary data).
###end p 54
###begin title 55
Sensitization protocol and indomethacin treatment
###end title 55
###begin p 56
###xml 75 85 75 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
All mice were continuously fed with a gluten-free diet and water available ad libitum.
###end p 56
###begin p 57
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 180 183 <span type="species:ncbi:31658">CFA</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 566 569 <span type="species:ncbi:31658">CFA</span>
###xml 602 606 <span type="species:ncbi:4530">rice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 752 755 <span type="species:ncbi:31658">CFA</span>
Mice were sensitized by injecting intraperitoneally (ip) 500 microg of gluten (Sigma-Aldrich, Ontario) dissolved in 0.02 mM acetic acid in 50 microl of Complete Freund's Adjuvant (CFA, Sigma-Aldrich, Ontario). One week after sensitization, gluten challenge was performed 3 times on a weekly basis by intragastric gavage, for 7 weeks, using 2 mg of gluten dissolved in 0.02 mM acetic acid. Indomethacin was administered by gavage (Ovation Pharmaceuticals, Ontario) (3.5 mg/kg) 24 hours before the gluten challenge. Control groups consisted of a) non-sensitized mice (CFA only) subsequently gavaged with rice cereal (2 mg/0.02 mM acetic acid), b) gluten-sensitized mice subsequently gavaged with gluten (2 mg/0.02 mM acetic acid) c) non-sensitized mice (CFA only) subsequently gavaged with indomethacin (3.5 mg/kg).
###end p 57
###begin title 58
In vitro intestinal permeability
###end title 58
###begin p 59
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 831 833 821 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o-</italic>
###xml 1005 1006 995 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 563 574 <span type="species:ncbi:3704">horseradish</span>
Two sections of jejunum from each mouse were used for Ussing chamber studies. Briefly, 5 cm of jejunum samples were collected and divided into 2 segments. Each segment was opened along the mesenteric border, flattened and mounted in an Ussing chamber with an opening of 0.6 cm2. Tissues were bathed in oxygenated Krebs buffer containing 10 mM glucose (serosal side) or 10 mM mannitol (luminal side) at 37degreesC. After a 20-minute equilibration period, conductance (G: mS/cm2) were recorded. Mucosal to serosal transport of macromolecules was assessed by adding horseradish peroxidase (HRP; type II, Sigma-Aldrich, Ontario), a commonly used macromolecular marker, in the luminal side. Serosal samples (500 microl) were obtained at 30 minutes intervals for 2 hours. Intact HRP was assessed using a modified Worthington method with o-dianosidine dihydrochloride (Sigma-Aldrich, Ontario) as the substrate, and mucosal to serosal fluxes were calculated according to standard formulae and expressed as pmol/cm2/hr.
###end p 59
###begin title 60
Examination of epithelial cell injury
###end title 60
###begin p 61
###xml 814 815 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1568 1569 1554 1555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
###xml 1398 1403 <span type="species:ncbi:10090">mouse</span>
###xml 1476 1481 <span type="species:ncbi:10090">mouse</span>
###xml 1485 1489 <span type="species:ncbi:10090">mice</span>
Jejunal sections were obtained and immediately fixed in 2.5% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer (pH 7.4) for 2 hours, transferred to sodium cacodylate buffer and stored at 4degreesC overnight. Tissues were subsequently processed for electron microscopy, and photomicrographs were prepared. Ultra-structural epithelial damage was evaluated in enterocytes by the presence of alterations in brush border, mitochondrial edema and tight junction (TJ) morphology. Epithelial damage was determined by transmission electron microscope (JEOL, Tokyo) of enterocytes in sections from 4-6 animals in each of the 4 study groups. The number of mitochondria with disrupted cristae within the apical region of enterocytes were counted on coded 5000x magnification photomicrographs measuring a total of 300 microm2 (125-250 mitochondria/photomicrographs, 5 photomicrographs/mouse, 6 mice/group) using Adobe CS3 Extended (Adobe Systems Incorporated, California). The fraction of altered mitochondria, defined as number of mitochondria with disrupted cristae divided by total number of mitochondria in a view, was calculated. Mitochondria on the edge of micrographs were excluded for evaluation, since neither their boundaries nor area could be accurately determined. The fraction of disrupted TJ structure was calculated as total altered TJ divided by total number of TJ evaluated in 20 fields per mouse in a blinded manner (3-20 tight junctions/field, 60-400 tight junctions/mouse, 4 mice/group). A field is defined as one square in the EM grid, measuring 8100 microm2.
###end p 61
###begin title 62
Apical junctional analysis by quantitative real-time PCR
###end title 62
###begin p 63
###xml 743 771 686 714 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGACACCAAAGCATGTGTGAG-3&#8242;</named-content>
###xml 776 801 719 744 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">3&#8242;-GGCATTCCTGCTGGTTACA-5&#8242;</named-content>
Total RNA from a 30-60 mg proximal small intestine section was isolated using RNeasy mini kit (Qiagen, Ontario). cDNA was synthesized from 2 microg of purified total RNA using M-MLV reverse transcriptase (Invitrogen, Ontario). Quantitative real-time PCR was performed with 1:20 dilutions of cDNA. The reaction consisted of iQtrade mark SYBR Green Supermix (Bio-rad, Ontario) for quantitative PCR, primers at 0.5 microM, and 1 microl of cDNA. Amplification was performed using iQ5 Real-Time Detection System at 95degreesC for 3 min followed by 37 cycles at 94degreesC for 15 s, 55degreesC (ZO-1) or 58degreesC (E-Cadherin) or 59degreesC (GAPDH) for 20 s, and 72degreesC for 25 s. Q Real-time PCR was performed using the following primers: ZO-1 5'-AGGACACCAAAGCATGTGTGAG-3'/and 3'-GGCATTCCTGCTGGTTACA-5';
###end p 63
###begin p 64
###xml 11 37 11 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCACATATGTAGCTCTCATC-3&#8242;</named-content>
###xml 42 67 42 67 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCTTCACAGTCACACACATG-3&#8242;</named-content>
###xml 75 99 75 99 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCATGGAGAAGGCTGGGG-3&#8242;</named-content>
###xml 104 130 104 130 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAAAGTTGTCATGGATGACC-3&#8242;</named-content>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Pfaffl1">[52]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Pfaffl1">[52]</xref>
E-Cadherin 5'-GCACATATGTAGCTCTCATC-3' and 5'CCTTCACAGTCACACACATG-3'. GAPDH 5'-CCATGGAGAAGGCTGGGG-3' and 5'-CAAAGTTGTCATGGATGACC-3' was used as housekeeping gene. CT values reported by iQ5 software were used in the study. PCR efficiencies for each amplicon were determined by making 10-fold serial dilutions of cDNA and then amplifying the cDNA using primers to both the gene of interest and housekeeping gene. Relative expression levels were calculated using the Pfaffl method [52], with efficiency correction for each primer set, using REST software [52]. A melting curve analysis was performed by heating the reactions from 50degrees to 99degreesC in 0.2degreesC intervals while monitoring fluorescence.
###end p 64
###begin title 65
Splenocyte proliferation, cell cultures and cytokine analysis
###end title 65
###begin p 66
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Lindfors1">[54]</xref>
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 203 204 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 348 349 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Peptic-tryptic digests of gliadin (PT-gliadin) was prepared as described previously [54]. Spleen cells were harvested and cultured (4x105 cells/well) in 96-well tissue culture plates at 37degreesC, 5% CO2 for 72 h in the presence or absence of 500 microg/ml PT-gliadin and/or 5 microg/ml indomethacin. The cultures were pulsed with 1 microCi/well [3H]-thymidine for 18 h. The cultured cells were harvested onto glass fibre filters using Filtermate harvester (Cambridge Technology, Massachusetts). The radioactivity incorporated was determined with a Beta Scintillation Counter (Beckman, California). Results are expressed as stimulation index (SI) and calculated as: SI = (mean cpm of triplicate cultures containing antigen)/(mean cpm of cells cultured with medium alone).
###end p 66
###begin p 67
Splenocyte supernatants were collected 48 h after incubation with or without PT-gliadin and/or indomethacin. The presence of pro-inflammatory cytokines in the supernatant was measured using pro-inflammatory CBA kit (BD Bioscience, California) and analyzed using BD FACSarray Bioanalyzer System (BD Bioscience, California).
###end p 67
###begin title 68
Fluorescent in situ hybridisation (FISH)
###end title 68
###begin p 69
###xml 41 49 41 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006472.s009">Table S1</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Amann1">[55]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Wallner1">[56]</xref>
###xml 1460 1464 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sokol1">[57]</xref>
###xml 1466 1470 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sanz2">[58]</xref>
###xml 1608 1612 1578 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Sanz2">[58]</xref>
Oligonucleotide probes are summarized in Table S1. The group-specific probes were labeled at the 5'-end with fluorescein isothiocyanate (FITC), showing green fluorescence. EUB 338 probe, targeting conserved sequences within the bacterial domain, was used as positive control [55]. NON EUB 338 probe was used as negative control to eliminate the background fluorescence [56]. Both control probes were labelled at the 5'end with either the indocyanine dye Cy3, showing red fluorescence, or with FITC. Aliquots of 36 microl fixed samples were incubated with 4 microl of each fluorescent probe (50 ng/microl) in hybridization solution (10 mM Tris-HCl, 0.9 M NaCl, pH 8.0, and 10% [w/v] sodium dodecyl sulphate) at appropriate temperature (45-50degreesC) overnight. Afterwards, bacterial cells were incubated with 400 microl washing solution (10 mM Tris-HCl, 0.9 M NaCl, pH 8.0) at 50 degreesC for 30 min to remove non-specific binding of the probes. Hybridized cells were finally pelleted by centrifugation (12 000 g for 5 min) and resuspended in 400 ml of PBS for flow cytometry detection. Bacterial groups were enumerated by combining each FITC-labelled group-specific probe with the EUB 338-Cy3 probe, and expressed as a ratio of cells hybridizing with the FITC-labelled specific probe to cells hybridizing with the EUB 338-Cy3 probe. This proportion was corrected by subtracting the background fluorescence obtained with the negative control probe NON EUB 338 [57], [58]. Flow cytometry detections were performed using anEPICS(R) XL-MCL flow cytometer (Beckman Coulter, Florida, USA) as previously described [58]. This instrument is equipped with two light scatter detectors that measure forward (FSC) and side scatter (SSC) and fluorescence detectors that detect appropriately filtered light at green (FL1, 525 nm) and red-orange (FL3, 620 nm) wavelengths. The event rate was kept at the lowest setting (200-300 events per second) to avoid cell coincidence. A total of 15, 000 events were recorded in a list mode file and analyzed with the System II V.3 software (Beckman Coulter).
###end p 69
###begin title 70
Statistical Analysis
###end title 70
###begin p 71
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006472-Pfaffl2">[53]</xref>
Statistical analysis was performed using ANOVA with post-hoc test for simple and multiple comparisons, respectively. Nonparametric statistical significance of relative RNA expression was calculated with REST software [53] by a pairwise fixed reallocation randomization test with 50,000 repeats. Data were presented as means+/-standard error (SEM).
###end p 71
###begin title 72
Supporting Information
###end title 72
###begin p 73
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
Weight gain over 7-week period. Both gluten-sensitized and indomethacin treated mice exhibited a decreased rate of weight gain compared to non-sensitized controls. Gluten-sensitized mice treated with indomethacin exhibited more pronounced weight gain retardation compared to controls and to gluten-sensitized and indomethacin treated mice. Data represent the means+/-SEM of 10 mice/group.
###end p 73
###begin p 74
(0.08 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
Conductance and HRP flux in C57Bl/6 mice. Gluten and/or indomethacin treatment did not lead to changes in tissue conductance. HRP flux was increased in indomethacin treated mice, but not in gluten sensitized mice without indomethacin. Data represent the means+/-SEM of 10 mice/group.
###end p 76
###begin p 77
(0.09 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 225 229 <span type="species:ncbi:10090">mice</span>
ZO-1 RNA expression relative to non-sensitized controls. No significant differences were seen when RNA expression for each treatment group was analyzed relative to non-sensitized controls. Data represent the means+/-SEM of 6 mice/group.
###end p 79
###begin p 80
(3.00 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
Splenocyte proliferation after incubation with PT-gliadin and/or indomethacin. Stimulation with indomethacin alone did not increase splenocyte proliferation in gluten-sensitized mice. In-vitro stimulation with both PT-gliadin and indomethacin, did not further enhance cell proliferation compared to PT-gliadin alone. Data represent the means+/-SEM of 6 mice/group.
###end p 82
###begin p 83
(0.07 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
IFN-gamma levels in supernatant of cultured splenocytes after incubation with PT-gliadin and/or indomethacin. Stimulation with indomethacin alone did not increase IFN-gamma production in gluten-sensitized mice. In-vitro stimulation with PT-gliadin and indomethacin did not increase IFN-gamma levels compared to PT gliadin alone. Data represent the means+/-SEM of 6 mice/group. ND = not detectable.
###end p 85
###begin p 86
(0.07 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
Systemic antibodies against commensals. Gluten-sensitized plus indomethacin-treated mice exhibited increased serum antibodies against aerobic and anaerobic bacteria as assessed by median fluorescent intensity signal of APC-labelled anti-IgM (1:20 serum dilution). Negative controls include serum (-): no serum and bacteria (-): no bacteria. Data represent the means+/-SEM of 6 mice/group.
###end p 88
###begin p 89
(0.11 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
Positive and negative systemic antibodies against commensals. (A) Salmonella M557, which is a pathogen not present in our HLA-DQ8/HCD4 mice colony, was stained with serum antibodies from indomethacin plus gluten treated mice. Results show the absence of positive antibodies against Salmonella, thus the specificity of the technique. (B) Salmonella M557 was stained with serum antibodies from Salmonella M557 infected mice. Results show the absence of positive antibodies against Salmonella.
###end p 91
###begin p 92
(0.09 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
Immunohistochemistry for F4/80+ cells. Staining for F4/80+ was increased in gluten sensitized mice. Infiltration of F4/80+ cells was most marked in gluten-sensitized mice treated with indomethacin. Data represent the means+/-SEM of 6 mice/group. Representative picture of macrophage infiltration in the lamina propria from (A) control mice (B) gluten-sensitized mice (C) indomethacin-treated mice (D) gluten-sensitized plus indomethacin treated mice.
###end p 94
###begin p 95
(0.47 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
Oligonucleotide probes and hybridization conditions used in FCM-FISH analysis of intestinal bacteria.
###end p 97
###begin p 98
(0.06 MB DOC)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
Immunohistochemistry for macrophages.
###end p 100
###begin p 101
(0.03 MB DOC)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 31 36 <span type="species:ncbi:33453">Julia</span>
We acknowledge Markus Geuking, Julia Cahenzli and Giada de Palma for their excellent assistance.
###end p 103
###begin title 104
References
###end title 104
###begin article-title 105
Exploring the iceberg-the spectrum of celiac disease.
###end article-title 105
###begin article-title 106
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease.
###end article-title 106
###begin article-title 107
###xml 34 42 <span type="species:ncbi:9606">children</span>
Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus.
###end article-title 107
###begin article-title 108
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').
###end article-title 108
###begin article-title 109
Celiac disease without villous atrophy: revision of criteria called for.
###end article-title 109
###begin article-title 110
Role of lymphocytic immunophenotyping in the diagnosis of gluten-sensitive enteropathy with preserved villous architecture.
###end article-title 110
###begin article-title 111
###xml 61 64 <span type="species:ncbi:9606">Man</span>
Between celiac disease and irritable bowel syndrome: The 'No Man's Land' of gluten sensitivity.
###end article-title 111
###begin article-title 112
###xml 44 49 <span type="species:ncbi:4565">Wheat</span>
###xml 113 117 <span type="species:ncbi:10090">Mice</span>
HLA-DQ Determines the Response to Exogenous Wheat Proteins: A Model of Gluten Sensitivity in Transgenic Knockout Mice.
###end article-title 112
###begin article-title 113
###xml 74 78 <span type="species:ncbi:10090">mice</span>
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.
###end article-title 113
###begin article-title 114
###xml 70 85 <span type="species:ncbi:10090">transgenic mice</span>
Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization.
###end article-title 114
###begin article-title 115
###xml 95 110 <span type="species:ncbi:10090">transgenic mice</span>
Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
###end article-title 115
###begin article-title 116
Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium.
###end article-title 116
###begin article-title 117
Celiac disease.
###end article-title 117
###begin article-title 118
Celiac disease: pathogenesis of a model immunogenetic disease.
###end article-title 118
###begin article-title 119
Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
###end article-title 119
###begin article-title 120
Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.
###end article-title 120
###begin article-title 121
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria.
###end article-title 121
###begin article-title 122
Alterations in intestinal permeability.
###end article-title 122
###begin article-title 123
###xml 27 35 <span type="species:ncbi:9606">patients</span>
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis.
###end article-title 123
###begin article-title 124
###xml 97 105 <span type="species:ncbi:9606">patients</span>
In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease.
###end article-title 124
###begin article-title 125
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease.
###end article-title 125
###begin article-title 126
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.
###end article-title 126
###begin article-title 127
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.
###end article-title 127
###begin article-title 128
Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins.
###end article-title 128
###begin article-title 129
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.
###end article-title 129
###begin article-title 130
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.
###end article-title 130
###begin article-title 131
Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation.
###end article-title 131
###begin article-title 132
###xml 106 110 <span type="species:ncbi:10090">mice</span>
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.
###end article-title 132
###begin article-title 133
Bacterial translocation from the gastrointestinal tract.
###end article-title 133
###begin article-title 134
Regulation of adherens junctions and epithelial paracelular permebility: a novel function for polyamines.
###end article-title 134
###begin article-title 135
Rapid disruption of intestinal barrier fucntion by gliadin nvolves altered expression of apical junctional proteins.
###end article-title 135
###begin article-title 136
###xml 96 104 <span type="species:ncbi:9606">children</span>
Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with celaic sprue.
###end article-title 136
###begin article-title 137
Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen.
###end article-title 137
###begin article-title 138
Immunologically mediated transport of ions and macromolecules.
###end article-title 138
###begin article-title 139
###xml 23 27 <span type="species:ncbi:10116">rats</span>
Resistance of germfree rats to indomethacin-induced intestinal lesions.
###end article-title 139
###begin article-title 140
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis.
###end article-title 140
###begin article-title 141
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota.
###end article-title 141
###begin article-title 142
Compartmentalization of the mucosal immune responses to commensal intestinal bacteria.
###end article-title 142
###begin article-title 143
Screening New Drugs for Immunotoxic Potential: I. Assessment of the Effects of Conventional Nonsteroidal Anti-Inflammatory Drugs and Selective COX-2 Inhibitors on In Vitro and In Vivo Phagocytic Activity.
###end article-title 143
###begin article-title 144
The functional interactions of commensal bacteria with intestinal secretory IgA.
###end article-title 144
###begin article-title 145
Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.
###end article-title 145
###begin article-title 146
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
###end article-title 146
###begin article-title 147
Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease.
###end article-title 147
###begin article-title 148
Elevated serum anti-saccharomices cerevisiae, anti-I2, and anti-ompW antibody levels in patietns with suspicion of celiac disease.
###end article-title 148
###begin article-title 149
###xml 22 46 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet.
###end article-title 149
###begin article-title 150
Celiac disease as a model of gastrointestinal inflammation.
###end article-title 150
###begin article-title 151
A role for bacteria in celiac disease?
###end article-title 151
###begin article-title 152
###xml 19 38 <span type="species:ncbi:1582">Lactobacillus casei</span>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity.
###end article-title 152
###begin article-title 153
###xml 59 67 <span type="species:ncbi:9606">children</span>
Imbalance in the composition of the duodenal microbiota of children with coeliac disease.
###end article-title 153
###begin article-title 154
###xml 67 75 <span type="species:ncbi:9606">children</span>
Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis.
###end article-title 154
###begin article-title 155
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes.
###end article-title 155
###begin article-title 156
A new mathematical model for relative quantification in real-time RT-PCR.
###end article-title 156
###begin article-title 157
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.
###end article-title 157
###begin article-title 158
###xml 15 37 <span type="species:ncbi:302911">Bifidobacterium lactis</span>
###xml 84 89 <span type="species:ncbi:4565">wheat</span>
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture.
###end article-title 158
###begin article-title 159
Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations.
###end article-title 159
###begin article-title 160
Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms.
###end article-title 160
###begin article-title 161
###xml 74 90 <span type="species:ncbi:562">Escherichia coli</span>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis.
###end article-title 161
###begin article-title 162
###xml 67 75 <span type="species:ncbi:9606">children</span>
Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis.
###end article-title 162
###begin p 163
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 163
###begin p 164
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a grant by the Canadian Association of Gastroenterology (CAG)/Canadian Institute of Health Research (CIHR) and by the Canadian Celiac Association New Investigator Award (E. Verdu). E. Verdu holds a McMaster University Dep. of Medicine Internal Career Research Award. Dr K. McCoy holds a Canada Research Chair in Gastrointestinal Immunology; Drs. Murray and David were supported in part by R01 DK71003.
###end p 164

